Skip to main content
Clinical Trials/JPRN-jRCT1092220164
JPRN-jRCT1092220164
Completed
Phase 3

Trans-arterial embolization of dural arteriovenous fistula using ONYX liquid embolic system. multi-center, prospective registry trial - ONYX-dAVF

obuyuki Sakai0 sites22 target enrollmentStarted: February 14, 2014Last updated:

Overview

Phase
Phase 3
Status
Completed
Sponsor
obuyuki Sakai
Enrollment
22

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
>= 20age old to <= 80age old (—)
Sex
All

Inclusion Criteria

  • 1\. modified Rankin Scale 4 or less 2\. primary or recurrence of dural arteriovenous fistula
  • 3\. difficult to cure by trensvenous embolization
  • 4\. exist feeding artery suitable for ONYX embolization

Exclusion Criteria

  • 1\. not indicated for intravenous heparin
  • 2\. difficult to follow\-up for 6 months
  • 3\. allergy for iodine contrast
  • 4\. allergy for tantalum

Investigators

Sponsor
obuyuki Sakai

Similar Trials